内镜逆行阑尾炎治疗术治疗非复杂性急性阑尾炎的系统评价与荟萃分析
该系统评价与荟萃分析纳入8项研究共2005例非复杂性急性阑尾炎患者,比较内镜逆行阑尾炎治疗术(ERAT)与腹腔镜阑尾切除术(LA)及抗生素治疗的效果。结果显示ERAT相较LA治疗成功率显著更低且复发率显著更高,相较抗生素治疗成功率有升高趋势且复发率有降低趋势但未达统计学显著,不良事件发生率显著低于抗生素治疗。
要点
- ERAT相较腹腔镜阑尾切除术治疗成功率更低且复发率更高。
- ERAT相较抗生素治疗不良事件发生率显著更低。
- ERAT相较抗生素治疗的成功率与复发率差异未达统计学显著。
核心结论
- ERAT是治疗非复杂性急性阑尾炎有前景但非确定性的替代方案,在保留器官和减少不良事件方面相较抗生素有优势。
- ERAT相对较低的成功率和较高的复发率目前使其尚不能完全替代阑尾切除术。
研究设计与样本
- 系统评价与荟萃分析,检索PubMed、Embase、Web of Science和Cochrane Library数据库,覆盖从建库至2025年1月。
- 共纳入8项研究,包括3项随机对照试验和5项回顾性研究,合计样本量2005例参与者。
- 使用Review Manager 5.4进行荟萃分析,适用时采用随机效应模型。
主要发现
- 与腹腔镜阑尾切除术组相比,ERAT组治疗成功率显著更低(OR 0.15,95%CI 0.04-0.57,P=0.005)。
- 与腹腔镜阑尾切除术组相比,ERAT组复发率显著更高(OR 7.68,95%CI 2.32-25.46,P=0.0009)。
- 与抗生素治疗组相比,ERAT组治疗成功率更高(OR 2.10,95%CI 0.95-4.64,P=0.07),但差异未达统计学显著。
- 与抗生素治疗组相比,ERAT组复发率更低(OR 0.31,95%CI 0.09-1.07,P=0.06),但差异未达统计学显著。
- ERAT相关不良事件总体发生率显著低于抗生素治疗(OR 0.09,95%CI 0.02-0.50,P=0.005)。
临床怎么用
- 对于非复杂性急性阑尾炎,ERAT可作为保留阑尾的微创选项,但需权衡其较低治疗成功率和较高复发率。
- 与抗生素治疗相比,ERAT不良事件更少,但成功率与复发率优势未达统计学显著。
- 目前证据尚不支持ERAT完全替代阑尾切除术,临床决策应个体化。
局限性
- 纳入研究数量有限(8项),且包含5项回顾性研究,可能存在偏倚。
- 与抗生素治疗比较的成功率和复发率差异未达统计学显著,结论需谨慎解读。
- 需要进一步高质量研究来明确ERAT在临床实践中的角色。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute appendicitis is a prevalent abdominal emergency, with appendectomy and antibiotic therapy being the conventional mainstays of treatment. Recently, endoscopic retrograde appendicitis therapy (ERAT) has emerged as a promising minimally invasive alternative. This study aims to evaluate the feasibility and effectiveness of ERAT in the management of uncomplicated acute appendicitis. METHODS: A systematic review of the literature was performed by searching the PubMed, Embase, Web of Science, and Cochrane Library databases, covering records from inception to January 2025. Meta-analyses were conducted using Review Manager 5.4, employing a random-effects model when applicable. RESULTS: A total of 8 studies were included, consisting of three randomized controlled trials and five retrospective studies, with a combined sample size of 2005 participants. When compared with the laparoscopic appendectomy (LA) group, the ERAT group demonstrated a significantly lower treatment success rate (odds ratio [OR] 0.15, 95% confidence interval [CI] 0.04-0.57, P = 0.005) and a significantly higher recurrence rate (OR 7.68, 95% CI 2.32-25.46, P = 0.0009). In contrast, compared with the antibiotic therapy group, the ERAT group exhibited a higher treatment success rate (OR 2.10, 95% CI 0.95-4.64, P = 0.07) and a lower recurrence rate (OR 0.31, 95% CI 0.09-1.07, P = 0.06), although these differences did not reach statistical significance. Additionally, the overall incidence of adverse events associated with ERAT was significantly lower than that observed with antibiotic therapy (OR 0.09, 95% CI 0.02-0.50, P = 0.005). CONCLUSION: ERAT is a promising but not yet definitive alternative for uncomplicated acute appendicitis, with advantages in organ preservation and fewer adverse events compared to antibiotics. However, relatively low success rate and high recurrence rate of ERAT currently prevent it from completely replacing appendectomy. Further high-quality studies are needed to better define its role in clinical practice.
引用
- Li Z, Chen Y, Zhang X, et al. Feasibility and effectiveness of endoscopic retrograde appendicitis therapy for uncomplicated acute appendicitis: a systematic review and meta-analysis. Surg Endosc. 2025. PMID: 40369281. doi:10.1007/s00464-025-11797-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。